FDA's final guidance on patient-reported outcomes measurements adds more detail and information on practical application to the draft guidance issued several years ago - in keeping with the comments made on the draft
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says the EU pharma reform is “not an improvement on the status quo” in its current form.
Oncology trial sponsors in the UK are being invited to participate in a pilot that aims to tackle duplication and variation in pharmacy reviews, which are an important part of setting up clinical trials in the National Health Service.
The new Advisory Committee on Immunization Practices voted for new recommendations on the decades-old thimerosal safety issue and lays intellectual groundwork to revisit other past controversies and decisions.
